Form 4 for RARE Ultragenyx Pharmaceutical Inc.
Accepted 2023-06-09 00:00:00 ET · period of report 2023-06-07 · accession 0001209191-23-035687 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-09 | 2023-06-07 | RARE | Dunsire Deborah | Dir | A - Grant | $0.00 | +3,860 | 19.7K | +24% | $0 |
| D | 2023-06-09 | 2023-06-07 | RARE | Dunsire Deborah | Dir | A - Grant | $0.00 | +7,110 | 7,110 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-07 | A | A | 3,860 | $0.00 | 19,730 | D | — | — | (F1) Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-06-07 | A | A | 7,110 | $0.00 | 7,110 | D | $51.82 · — to 2033-06-07 | 7,110 Common Stock | (F2) The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024 |